BG103143A - Substituted pyrido- or pirimidocontaining 6,6- or 6,7-bicyclic derivatives - Google Patents

Substituted pyrido- or pirimidocontaining 6,6- or 6,7-bicyclic derivatives

Info

Publication number: BG103143A
Authority: BG; Bulgaria
Prior art keywords: pirimidocontaining; substituted pyrido; bicyclic derivatives; bicyclic; derivatives
Prior art date: 1996-08-06

Application number

BG103143A

Other languages

Bulgarian (bg)

English (en)

Inventor

Yuhpyng Chen

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-06

Filing date

1999-02-03

Publication date

1999-09-30

1999-02-03 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

1999-09-30 Publication of BG103143A publication Critical patent/BG103143A/xx

Links

102400000739 Corticotropin Human genes 0.000 abstract 1
101800000414 Corticotropin Proteins 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 abstract 1
229960000258 corticotropin Drugs 0.000 abstract 1
229940088597 hormone Drugs 0.000 abstract 1
239000005556 hormone Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

BG103143A 1996-08-06 1999-02-03 Substituted pyrido- or pirimidocontaining 6,6- or 6,7-bicyclic derivatives BG103143A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2345396P	1996-08-06	1996-08-06
PCT/IB1997/000918 WO1998005661A1 (en)	1996-08-06	1997-07-23	Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives

Publications (1)

Publication Number	Publication Date
BG103143A true BG103143A (en)	1999-09-30

Family

ID=21815208

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG103143A BG103143A (en)	1996-08-06	1999-02-03	Substituted pyrido- or pirimidocontaining 6,6- or 6,7-bicyclic derivatives

Country Status (40)

Country	Link
US (1)	US6492520B1 (xx)
EP (1)	EP0920429B1 (xx)
JP (1)	JP3345021B2 (xx)
KR (1)	KR20000029843A (xx)
CN (1)	CN1093130C (xx)
AP (1)	AP1096A (xx)
AR (1)	AR008829A1 (xx)
AT (1)	ATE232863T1 (xx)
AU (1)	AU709203B2 (xx)
BG (1)	BG103143A (xx)
BR (1)	BR9710808A (xx)
CA (1)	CA2262692C (xx)
CO (1)	CO4900060A1 (xx)
CZ (1)	CZ292806B6 (xx)
DE (1)	DE69719193T2 (xx)
DK (1)	DK0920429T3 (xx)
DZ (1)	DZ2289A1 (xx)
EA (1)	EA003188B1 (xx)
ES (1)	ES2191183T3 (xx)
GT (1)	GT199700089A (xx)
HR (1)	HRP970432B1 (xx)
ID (1)	ID17980A (xx)
IL (1)	IL128188A0 (xx)
IS (1)	IS4948A (xx)
MA (1)	MA24296A1 (xx)
NO (1)	NO313293B1 (xx)
NZ (1)	NZ333727A (xx)
OA (1)	OA10970A (xx)
PA (1)	PA8435201A1 (xx)
PE (1)	PE97098A1 (xx)
PL (1)	PL331602A1 (xx)
SA (1)	SA97180334A (xx)
SK (1)	SK14099A3 (xx)
TN (1)	TNSN97135A1 (xx)
TR (1)	TR199900228T2 (xx)
TW (1)	TW550265B (xx)
UY (1)	UY24655A1 (xx)
WO (1)	WO1998005661A1 (xx)
YU (1)	YU5399A (xx)
ZA (1)	ZA976954B (xx)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6187777B1 (en)	1998-02-06	2001-02-13	Amgen Inc.	Compounds and methods which modulate feeding behavior and related diseases
ES2221426T3 (es)	1998-08-20	2004-12-16	Smithkline Beecham Corporation	Nuevos compuestos de triazol sustituidos.
CN1178941C (zh)	1998-11-12	2004-12-08	纽罗克里恩生物科学有限公司	Crf受体拮抗剂以及与其有关的方法
NZ510955A (en)	1998-11-12	2003-01-31	Neurocrine Biosciences Inc	Tricyclic nitrogen containing ring system useful as CRF receptor antagonists
US6432989B1 (en) *	1999-08-27	2002-08-13	Pfizer Inc	Use of CRF antagonists to treat circadian rhythm disorders
CO5271670A1 (es) *	1999-10-29	2003-04-30	Pfizer Prod Inc	Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas
KR20030016222A (ko) *	2000-02-14	2003-02-26	니뽄 다바코 산교 가부시키가이샤	수술후 스트레스 예방ㆍ치료제
WO2001062718A1 (en) *	2000-02-25	2001-08-30	Japan Tobacco, Inc.	Benzamide derivative and use thereof
AR030053A1 (es) *	2000-03-02	2003-08-13	Smithkline Beecham Corp	1h-pirimido [4,5-d] pirimidin-2-onas y sales, composiciones farmaceuticas, uso para la fabricacion de un medicamento y procedimiento para producirlas
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
GB0011964D0 (en)	2000-05-18	2000-07-05	Suyal N	Thick glass films with controlled refractive indices and their applications
BR0114829A (pt)	2000-10-23	2003-09-23	Smithkline Beecham Corp	Novos compostos
GB0117396D0 (en)	2001-07-17	2001-09-05	Glaxo Group Ltd	Chemical compounds
JP2005504808A (ja)	2001-09-26	2005-02-17	バイエル・フアーマシユーチカルズ・コーポレーシヨン	抗糖尿病薬としての１，６−ナフチリジン誘導体
JP4603268B2 (ja)	2002-04-19	2010-12-22	グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー	新規化合物
FR2846657B1 (fr) *	2002-11-05	2004-12-24	Servier Lab	Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK1625121T3 (da)	2002-12-20	2010-05-10	Pfizer Prod Inc	Pyrimidinderivater til behandling af abnorm cellevækst
US7109337B2 (en)	2002-12-20	2006-09-19	Pfizer Inc	Pyrimidine derivatives for the treatment of abnormal cell growth
GB0308208D0 (en) *	2003-04-09	2003-05-14	Glaxo Group Ltd	Chemical compounds
US8309562B2 (en)	2003-07-03	2012-11-13	Myrexis, Inc.	Compounds and therapeutical use thereof
US7618975B2 (en)	2003-07-03	2009-11-17	Myriad Pharmaceuticals, Inc.	4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2005020910A2 (en) *	2003-08-27	2005-03-10	Pharmacia Corporation	Cyclooxygenase-2 selective inhibitor and corticotropin releasing factor antagonist compositions for treating ischemic mediated cns disorders or injuries
EP2522670A1 (en) *	2004-04-07	2012-11-14	Takeda Pharmaceutical Company Limited	Heterocyclic CRF receptor antagonists
MXPA06011658A (es)	2004-05-14	2006-12-14	Pfizer Prod Inc	Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
WO2005111022A1 (en)	2004-05-14	2005-11-24	Pfizer Products Inc.	Pyrimidines derivatives for the treatment of abnormal cell growth
BRPI0510963A (pt)	2004-05-14	2007-11-20	Pfizer Prod Inc	derivados pirimidina para o tratamento do crescimento anormal de células
US8258145B2 (en)	2005-01-03	2012-09-04	Myrexis, Inc.	Method of treating brain cancer
CA2592900A1 (en)	2005-01-03	2006-07-13	Myriad Genetics Inc.	Nitrogen containing bicyclic compounds and therapeutical use thereof
US7423042B2 (en)	2005-03-25	2008-09-09	Glaxo Group Limited	Compounds
WO2006104917A2 (en) *	2005-03-25	2006-10-05	Glaxo Group Limited	Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives
TW200724142A (en)	2005-03-25	2007-07-01	Glaxo Group Ltd	Novel compounds
TWI389690B (zh) *	2005-03-25	2013-03-21	Glaxo Group Ltd	新穎化合物（一）
CN101321742B (zh)	2005-05-26	2012-08-29	神经元系统公司	用于治疗视网膜疾病的组合物和方法
NZ569817A (en)	2005-12-21	2011-10-28	Abbott Lab	Anti-viral compounds
WO2007081517A2 (en)	2005-12-21	2007-07-19	Abbott Laboratories	Anti-viral compounds
CN101384591A (zh) *	2005-12-21	2009-03-11	艾博特公司	抗病毒化合物
DE602006015861D1 (de)	2005-12-21	2010-09-09	Abbott Lab	Antivirale verbindungen
EP2345652A1 (en)	2005-12-21	2011-07-20	Abbott Laboratories	Antiviral compounds
WO2008133753A2 (en)	2006-12-20	2008-11-06	Abbott Laboratories	Anti-viral compounds
NZ612380A (en)	2008-12-09	2015-01-30	Gilead Sciences Inc	Modulators of toll-like receptors
US8551996B2 (en) *	2009-02-20	2013-10-08	Emory University	Compounds, compositions, methods of synthesis, and methods of treatment
EP2477987B1 (en)	2009-09-14	2018-01-10	Gilead Sciences, Inc.	Modulators of toll-like receptors
US9814701B2 (en)	2009-12-11	2017-11-14	Aldeyra Therapeutics, Inc.	Compositions and methods for the treatment of macular degeneration
WO2012088266A2 (en)	2010-12-22	2012-06-28	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
SI2861595T1 (sl)	2012-06-13	2017-04-26	Incyte Holdings Corporation	Substituirane triciklične spojine kot inhibitorji fgfr
US9388185B2 (en)	2012-08-10	2016-07-12	Incyte Holdings Corporation	Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
CN111135171B (zh)	2013-01-23	2023-09-08	奥尔德拉医疗公司	与毒性醛相关的疾病和治疗
ES2657451T3 (es)	2013-04-19	2018-03-05	Incyte Holdings Corporation	Heterocíclicos bicíclicos como inhibidores del FGFR
US10882868B2 (en)	2014-05-15	2021-01-05	Hoffmann-La Roche Inc.	Compounds for treating spinal muscular atrophy
UA119670C2 (uk) *	2014-05-15	2019-07-25	Ф. Хоффманн-Ля Рош Аг	Сполуки для лікування спінальної м'язової атрофії
TWI733652B (zh)	2014-07-11	2021-07-21	美商基利科學股份有限公司	用於治療ＨＩＶ之ｔｏｌｌ樣受體調節劑
TWI780423B (zh)	2014-09-16	2022-10-11	美商基利科學股份有限公司	類鐸受體調節劑的製備方法
ES2835717T3 (es)	2014-09-16	2021-06-23	Gilead Sciences Inc	Formas sólidas de un modulador de receptor de tipo Toll
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
CA2976790C (en)	2015-02-20	2024-02-27	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2016134294A1 (en)	2015-02-20	2016-08-25	Incyte Corporation	Bicyclic heterocycles as fgfr4 inhibitors
HK1255074A1 (zh)	2015-07-01	2019-08-02	Crinetics Pharmaceuticals, Inc.	生长抑素调节剂及其用途
CN118724806A (zh)	2015-08-21	2024-10-01	奥尔德拉医疗公司	氘化化合物和其用途
MD3413892T2 (ro) *	2016-02-12	2022-06-30	Cytokinetics Inc	Derivați de tetrahidroizochinolină
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
EP3658560A4 (en)	2017-07-25	2021-01-06	Crinetics Pharmaceuticals, Inc.	SOMATOSTAT IN MODULATORS AND USES THEREOF
JP7311162B2 (ja)	2017-10-10	2023-07-19	アルデイラセラピューティクス，インコーポレイテッド	炎症性障害の処置
KR20210018265A (ko)	2018-05-04	2021-02-17	인사이트 코포레이션	Fgfr 억제제의 고체 형태 및 이의 제조 방법
MX2020011639A (es)	2018-05-04	2021-02-15	Incyte Corp	Sales de un inhibidor de receptores de factor de crecimiento de fibroblastos (fgfr).
CN112714762A (zh)	2018-08-06	2021-04-27	奥尔德拉医疗公司	多晶型化合物及其用途
JP7505786B2 (ja)	2018-09-25	2024-06-25	アルデイラセラピューティクス，インコーポレイテッド	ドライアイ疾患を処置するための製剤
WO2020185532A1 (en)	2019-03-08	2020-09-17	Incyte Corporation	Methods of treating cancer with an fgfr inhibitor
US11786518B2 (en)	2019-03-26	2023-10-17	Aldeyra Therapeutics, Inc.	Ophthalmic formulations and uses thereof
CN113784954A (zh)	2019-05-02	2021-12-10	奥尔德拉医疗公司	多晶型化合物和其用途
US12098132B2 (en)	2019-05-02	2024-09-24	Aldeyra Therapeutics, Inc.	Process for preparation of aldehyde scavenger and intermediates
US11591329B2 (en)	2019-07-09	2023-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
JP7675711B2 (ja)	2019-10-14	2025-05-13	インサイト・コーポレイション	Ｆｇｆｒ阻害剤としての二環式複素環
WO2021076728A1 (en)	2019-10-16	2021-04-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2021113479A1 (en)	2019-12-04	2021-06-10	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
CR20220285A (es)	2019-12-04	2022-10-27	Incyte Corp	Derivados de un inhibidor de fgfr
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
JP2023526016A (ja)	2020-05-13	2023-06-20	アルデイラセラピューティクス，インコーポレイテッド	医薬製剤およびその使用
JP2024513575A (ja)	2021-04-12	2024-03-26	インサイト・コーポレイション	Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法
AR126102A1 (es)	2021-06-09	2023-09-13	Incyte Corp	Heterociclos tricíclicos como inhibidores de fgfr
EP4352060A1 (en)	2021-06-09	2024-04-17	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4605642A (en)	1984-02-23	1986-08-12	The Salk Institute For Biological Studies	CRF antagonists
US5063245A (en)	1990-03-28	1991-11-05	Nova Pharmaceutical Corporation	Corticotropin-releasing factor antagonism compounds
GB9300059D0 (en) *	1992-01-20	1993-03-03	Zeneca Ltd	Quinazoline derivatives
EP0674641B1 (en) *	1992-12-17	1999-03-03	Pfizer Inc.	Pyrrolopyrimidines as crf antagonists
TW444018B (en) *	1992-12-17	2001-07-01	Pfizer	Pyrazolopyrimidines
IL112249A (en)	1994-01-25	2001-11-25	Warner Lambert Co	Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
TW574214B (en) *	1994-06-08	2004-02-01	Pfizer	Corticotropin releasing factor antagonists
PL181895B1 (pl) *	1994-06-16	2001-10-31	Pfizer	Nowe pirazolo-i pirolopirydyny _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ PL PL PL PL
JP2898887B2 (ja) *	1994-08-31	1999-06-02	沖電気工業株式会社	Ｉｃカードの読み取り装置
EP0729758A3 (en) *	1995-03-02	1997-10-29	Pfizer	Pyrazolopyrimidines and pyrrolopyrimidines for the treatment of neuronal and other diseases
AU716993B2 (en) *	1995-05-12	2000-03-16	Neurogen Corporation	Novel deazapurine derivatives; a new class of CRF1 specific ligands
US6403599B1 (en) *	1995-11-08	2002-06-11	Pfizer Inc	Corticotropin releasing factor antagonists
ES2200039T3 (es) *	1995-12-08	2004-03-01	Pfizer Inc.	Derivados heterociclicos sustituidos como antagonistas de crf.
CN1090189C (zh)	1996-02-07	2002-09-04	詹森药业有限公司	吡唑并嘧啶类化合物
TW477787B (en)	1996-08-27	2002-03-01	Pfizer	Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same

1997
- 1997-07-23 AT AT97929472T patent/ATE232863T1/de not_active IP Right Cessation
- 1997-07-23 DE DE69719193T patent/DE69719193T2/de not_active Expired - Fee Related
- 1997-07-23 IL IL12818897A patent/IL128188A0/xx unknown
- 1997-07-23 US US09/242,076 patent/US6492520B1/en not_active Expired - Fee Related
- 1997-07-23 CA CA002262692A patent/CA2262692C/en not_active Expired - Fee Related
- 1997-07-23 BR BR9710808A patent/BR9710808A/pt not_active Application Discontinuation
- 1997-07-23 AU AU33563/97A patent/AU709203B2/en not_active Ceased
- 1997-07-23 CN CN97197079A patent/CN1093130C/zh not_active Expired - Fee Related
- 1997-07-23 WO PCT/IB1997/000918 patent/WO1998005661A1/en not_active Ceased
- 1997-07-23 EP EP97929472A patent/EP0920429B1/en not_active Expired - Lifetime
- 1997-07-23 KR KR1019997001005A patent/KR20000029843A/ko not_active Abandoned
- 1997-07-23 PL PL97331602A patent/PL331602A1/xx unknown
- 1997-07-23 SK SK140-99A patent/SK14099A3/sk unknown
- 1997-07-23 CZ CZ1999411A patent/CZ292806B6/cs not_active IP Right Cessation
- 1997-07-23 DK DK97929472T patent/DK0920429T3/da active
- 1997-07-23 YU YU5399A patent/YU5399A/sh unknown
- 1997-07-23 ES ES97929472T patent/ES2191183T3/es not_active Expired - Lifetime
- 1997-07-23 NZ NZ333727A patent/NZ333727A/xx unknown
- 1997-07-23 JP JP50775498A patent/JP3345021B2/ja not_active Expired - Fee Related
- 1997-07-23 EA EA199900083A patent/EA003188B1/ru not_active IP Right Cessation
- 1997-07-23 TR TR1999/00228T patent/TR199900228T2/xx unknown
- 1997-07-31 AP APAP/P/1997/001052A patent/AP1096A/en active
- 1997-08-04 GT GT199700089A patent/GT199700089A/es unknown
- 1997-08-04 TW TW086111115A patent/TW550265B/zh active
- 1997-08-05 PA PA19978435201A patent/PA8435201A1/es unknown
- 1997-08-05 ID IDP972708A patent/ID17980A/id unknown
- 1997-08-05 PE PE1997000679A patent/PE97098A1/es not_active Application Discontinuation
- 1997-08-05 UY UY24655A patent/UY24655A1/es not_active IP Right Cessation
- 1997-08-05 CO CO97044966A patent/CO4900060A1/es unknown
- 1997-08-05 ZA ZA976954A patent/ZA976954B/xx unknown
- 1997-08-05 AR ARP970103560A patent/AR008829A1/es not_active Application Discontinuation
- 1997-08-06 DZ DZ970139A patent/DZ2289A1/fr active
- 1997-08-06 TN TNTNSN97135A patent/TNSN97135A1/fr unknown
- 1997-08-06 HR HR970432A patent/HRP970432B1/xx not_active IP Right Cessation
- 1997-08-06 MA MA24755A patent/MA24296A1/fr unknown
- 1997-08-25 SA SA97180334A patent/SA97180334A/ar unknown
1999
- 1999-01-19 IS IS4948A patent/IS4948A/is unknown
- 1999-02-03 OA OA9900024A patent/OA10970A/en unknown
- 1999-02-03 BG BG103143A patent/BG103143A/xx unknown
- 1999-02-05 NO NO19990544A patent/NO313293B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
OA10970A (en)	2001-11-05
IL128188A0 (en)	1999-11-30
PA8435201A1 (es)	1999-12-27
EP0920429B1 (en)	2003-02-19
NO990544L (no)	1999-03-31
ZA976954B (en)	1999-02-05
MA24296A1 (fr)	1998-04-01
CO4900060A1 (es)	2000-03-27
EA003188B1 (ru)	2003-02-27
AP9701052A0 (en)	1997-10-31
HK1021734A1 (en)	2000-06-30
AP1096A (en)	2002-08-26
BR9710808A (pt)	1999-08-17
NO313293B1 (no)	2002-09-09
EA199900083A1 (ru)	1999-08-26
DE69719193D1 (de)	2003-03-27
CA2262692A1 (en)	1998-02-12
NZ333727A (en)	2000-09-29
PE97098A1 (es)	1999-01-12
DK0920429T3 (da)	2003-05-12
US6492520B1 (en)	2002-12-10
AU3356397A (en)	1998-02-25
NO990544D0 (no)	1999-02-05
HRP970432B1 (en)	2002-10-31
GT199700089A (es)	1999-01-26
TW550265B (en)	2003-09-01
JP2000501116A (ja)	2000-02-02
YU5399A (sh)	2002-03-18
AU709203B2 (en)	1999-08-26
TR199900228T2 (xx)	1999-03-22
CN1227552A (zh)	1999-09-01
AR008829A1 (es)	2000-02-23
UY24655A1 (es)	2000-09-29
TNSN97135A1 (fr)	2005-03-15
DZ2289A1 (fr)	2002-12-25
JP3345021B2 (ja)	2002-11-18
ATE232863T1 (de)	2003-03-15
IS4948A (is)	1999-01-19
ES2191183T3 (es)	2003-09-01
WO1998005661A1 (en)	1998-02-12
CZ292806B6 (cs)	2003-12-17
CZ41199A3 (cs)	2000-01-12
SK14099A3 (en)	2000-05-16
CN1093130C (zh)	2002-10-23
PL331602A1 (en)	1999-08-02
KR20000029843A (ko)	2000-05-25
CA2262692C (en)	2002-06-11
ID17980A (id)	1998-02-12
HRP970432A2 (en)	1998-08-31
DE69719193T2 (de)	2003-09-25
EP0920429A1 (en)	1999-06-09
SA97180334A (ar)	2005-12-03

Publication	Publication Date	Title
BG103143A (en)	1999-09-30	Substituted pyrido- or pirimidocontaining 6,6- or 6,7-bicyclic derivatives
BG103192A (en)	1999-09-30	Substituted 6,6-hetero-bicyclic derivatives
MX9802383A (es)	1998-08-30	Derivados de pirimidina como antagonistas del receptor 5ht26.
GR3030668T3 (en)	1999-10-29	Condensed indole derivatives as 5ht 4?-receptor antagonists.
GB2270075B (en)	1995-01-04	Substituted 2-phenyl-3-methoxypropenoate fungicides
ES2160949T3 (es)	2001-11-16	Derivados de fenilen-sulfonamida sustituidos en meta.
WO1990003375A3 (en)	1990-05-31	Fluoro substituted benzocycloheptapyridine compounds, compositions and methods of use
HU9400623D0 (en)	1994-06-28	Substituted 1h-imidazo(4,5-c)quinolin-4-amines, pharmaceutical compositions containing them as active components and intermediates for them
TR199801679T2 (xx)	2001-06-21	Osteoporoz i�in birle�tirme terapisi.
CA2286076A1 (en)	1998-10-29	Use of 5ht3 antagonists for promoting intestinal lavage
BG101401A (bg)	1997-12-30	Състави за орално приложение с удължено освобождаване на цисаприд
TR200001102T2 (tr)	2000-08-21	İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
AU5686196A (en)	1996-10-23	Use of an "immunodeficiency-virus suppressing lymphokine (ISL)" to inhibit the replication of viruses, in particular of retroviruses
AU2654692A (en)	1993-04-27	Pyrrolobenzoxazine derivatives as 5-ht agonists and antagonists
RU95106653A (ru)	1996-11-20	Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
AU7345391A (en)	1991-09-18	Derivative of beta-phenylisoserine, preparation and utilisation thereof
GR3017885T3 (en)	1996-01-31	Substituted aminoacid amide derivatives, their preparation and use as fungicide.
BG102213A (en)	1998-08-31	Endoparasiticidic composition based on didepsipeptides, new didepsipeptides and method for their preparation
MX9603199A (es)	1997-07-31	Antagonistas de receptores a endotelina.
AU566900B2 (en)	1987-11-05	2,3-dihydro-3-oxo-1h-isoindole derivatives
EP0562575A3 (en)	1993-12-29	N-substituted-3-(substited hydrazino)-benzenesulfonamide derivatives, prepation process thereof, and herbicidal compositions
AU1945288A (en)	1988-12-06	Pyridooxazinone-pyridazinone and pyrazolone compounds, cardiotonic compositions including the same, and their use
AU2859792A (en)	1993-06-03	5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes
SE8704272L (sv)	1988-05-04	Pharmaceutisk komposition
TR199701011A2 (xx)	1998-04-21	1-karba-(detia)-sefalosforin t�revleri.